- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

H.R. 2075
U.S. House•In House Committee
Summary
H.R. 2075, the Protecting Life and Integrity in Research Act of 2025, was introduced in the House on Mar 11, 2025 by Rep. Robert Onder (R) with 33 co-sponsors. It was referred to Energy And Commerce, and last saw action on Mar 11, 2025: Referred to the House Committee on Energy and Commerce.
Record
Text
H.R. 2075 has 33 co-sponsors.
hb2075/introduced-in-house.txt119 HR 2075 IH: Protecting Life and Integrity in Research Act of 2025U.S. House of Representatives2025-03-11text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.I 119th CONGRESS 1st Session H. R. 2075 IN THE HOUSE OF REPRESENTATIVES March 11, 2025 Mr. Onder (for himself, Mr. Smith of New Jersey , Mr. Latta , Mr. Kelly of Mississippi , Mrs. Miller of Illinois , Mr. Harris of Maryland , Mr. Green of Tennessee , Mr. LaMalfa , Mr. Grothman , Mr. Cloud , Mr. Self , Mr. Weber of Texas , Mr. Stauber , Mr. Ellzey , Mr. Ezell , Mr. Guest , Mr. Burchett , Mr. Crane , Mr. Fallon , Mrs. Biggs of South Carolina , Mr. Palmer , Mr. Biggs of Arizona , Ms. Greene of Georgia , and Mr. Fleischmann ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILLTo prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.1.Short titleThis Act may be cited as the Protecting Life and Integrity in Research Act of 2025 .2.No research involving human fetal tissue obtained pursuant to an induced abortion(a)In general(1)In generalNo Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion.(2)Development of new, ethical cell linesSubsection (a) does not limit the authority of any Federal department, agency, or office to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion.(3)Research involving human fetal tissue obtained after a miscarriage or stillbirth permittedAny research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act ( 42 U.S.C. 289g–1 ).(b)Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirthSection 498A of the Public Health Service Act ( 42 U.S.C. 289g–1 ) is amended—(1)in the section heading, by strikingtransplantation of fetal tissue and insertinghuman fetal tissue obtained after a miscarriage or stillbirth ;(2)by amending subsection (a) to read as follows:(a)Establishment of programThe Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.;(3)in subsection (b)—(A)in paragraph (1)(B), by inserting if the human fetal tissue is intended for transplantation, before the donation ; and(B)in paragraph (2)—(i)by striking subparagraph (A); and(ii)by redesignating subparagraphs (B) and (C) as (A) and (B), respectively;(4)in subsection (c)(1)(B), by striking pursuant to a spontaneous or induced abortion or pursuant to and inserting after a miscarriage or ; and(5)by amending subsection (g) to read as follows:(g)DefinitionsIn this section:(1)Human fetal tissueThe term human fetal tissue means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth.(2)MiscarriageThe term miscarriage means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.(3)StillbirthThe term stillbirth means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.(4)Unborn childThe term unborn child has the meaning given such term in section 1841(d) of title 18, United States Code..(c)Conforming repealSection 113 of the National Institutes of Health Revitalization Act of 1993 ( 42 U.S.C. 289g–1 note) is repealed.3.Prohibition against solicitation or knowing acquisition, receipt, or acceptance of a donation of human fetal tissue knowing that the tissue was obtained pursuant to an induced abortion(a)In generalSection 498B(c)(1) of the Public Health Service Act ( 42 U.S.C. 289g–2(c)(1) ) is amended to read as follows:(1)solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—(A)a human pregnancy was deliberately initiated to provide such tissue; or(B)the tissue was obtained pursuant to an induced abortion; or.(b)Conforming changesSection 498B of the Public Health Service Act ( 42 U.S.C. 289g–2 ), as amended by subsection (a), is further amended—(1)by striking subsection (b);(2)by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and(3)in subsection (c), as redesignated—(A)in paragraph (1), by striking (a), (b), or (c) and inserting (a) or (b) ; and(B)in paragraph (2), by striking or (b)(3) .
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2025-03-11
- Passed House
- Passed Senate
- Conference
- To President
- Became Law
To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue.
Sponsors
Rep. Robert Onder (R) sponsors H.R. 2075, and 33 members have co-sponsored it, 23 of them from the day it was introduced.

Rep. · R–MO-3 · Sponsor
Introduced Mar 11, 2025

Rep. · R–AZ-5 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–SC-3 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–TN-2 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–TX-27 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–AZ-2 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–TX-6 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–MS-4 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–TX-4 · Co-sponsor
Joined Mar 11, 2025 · Original

Rep. · R–TN-3 · Co-sponsor
Joined Mar 11, 2025 · Original
Committees
H.R. 2075 went before 1 committee: Energy and Commerce.
Actions
H.R. 2075 has taken 2 actions since Mar 11, 2025.
| Chamber | Action | |||
|---|---|---|---|---|
Mar 11, 2025 | House | Introduced in House | ||
Mar 11, 2025 | House | Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee |
Votes
H.R. 2075 has not gone to a roll call.
Related bills
1 bill is related to H.R. 2075.
Titles
H.R. 2075 goes by 3 titles, 1 of them short titles.
- Protecting Life and Integrity in Research Act of 2025 — Display Title
- Protecting Life and Integrity in Research Act of 2025 — Short Title(s) as Introduced
- To prohibit the Federal Government from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and to prohibit the solicitation or knowing acquisition, receipt, or acceptance of a donation of such tissue. — Official Title as Introduced
Lobbying
1 client hired 1 firm and 8 registered lobbyists who named H.R. 2075 in 3 quarterly filings, 2025. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.
Filed under Budget/Appropriations, Civil Rights/Civil Liberties, Constitution, Defense, District of Columbia, Family issues/Abortion/Adoption, Foreign Relations, Government Issues.
Clients
Who paid to be heard, by how many filings named the bill.
| Client | Business | State | Firms | Filings | Reported |
|---|---|---|---|---|---|
| SUSAN B ANTHONY LIST | — | Virginia | 1 | 3 | — |
Firms
Registrants who filed on the bill, by filings.
| Registrant | Clients | Filings | Reported |
|---|---|---|---|
| SUSAN B ANTHONY LIST | 1 | 3 | — |
Lobbyists
Named on the filings that cite the bill.
| Lobbyist | Firms | Clients | Filings |
|---|---|---|---|
| AUTUMN CHRISTENSEN | 1 | 1 | 3 |
| BILLY VALENTINE | 1 | 1 | 3 |
| GWEN CHARLES | 1 | 1 | 3 |
| JAMIE DANGERS | 1 | 1 | 3 |
| JEREMY PILZ | 1 | 1 | 3 |
| KATIE GLENN DANIEL | 1 | 1 | 3 |
| MARILYN MUSGRAVE | 1 | 1 | 3 |
| MARJORIE DANNENFELSER | 1 | 1 | 3 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.
| Client | Registrant | Period | Reported | Document |
|---|---|---|---|---|
| SUSAN B ANTHONY LIST | SUSAN B ANTHONY LIST | 2025 first_quarter | $600K | 1st Quarter - Report |
| SUSAN B ANTHONY LIST | SUSAN B ANTHONY LIST | 2025 second_quarter | $490K | 2nd Quarter - Report |
| SUSAN B ANTHONY LIST | SUSAN B ANTHONY LIST | 2025 third_quarter | $360K | 3rd Quarter - Report |
Classification
The Congressional Research Service files H.R. 2075 under Health, one of its 31 policy areas.
CRS Subjects
CRS assigns every bill one policy area from its 31; H.R. 2075’s is Health.
hr2075/policy-areas.txtConstitutional authority
The clause the sponsor cites as Congress’s power to enact H.R. 2075, as entered in the Congressional Record.
[Congressional Record Volume 171, Number 45 (Tuesday, March 11, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. ONDER:H.R. 2075.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H1152]
Source: congress.gov · legiscan.com
